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Abstract  
Precise control of gene expression using exogenous factors is of great significance. To 
develop ideal inducible expression systems for streptomycetes, new genetic parts, 
oxytetracycline responsive repressor OtrR, operator otrO and promoter otrBp from 
Streptomyces rimosus, were selected de novo and characterized in vivo and in vitro. 
OtrR showed strong affinity to otrO (KD = 1.7×10
-10
 M) and oxytetracycline induced 
dissociation of the OtrR/DNA complex in a concentration-dependent manner. Based 
on these genetic parts, a synthetic inducible expression system Potr* was optimized. 
Induction of Potr* with 0.01-4 µM of oxytetracycline triggered a wide-range 
expression level of gfp reporter gene in different Streptomyces species. Benchmarking 
Potr* against the widely used constitutive promoters ermE* and kasOp* revealed 
greatly enhanced levels of expression when Potr* was fully induced. Finally, Potr* 
was used as a tool to activate and optimize the expression of the silent jadomycin 
biosynthetic gene cluster in Streptomyces venezuelae. Altogether, the synthetic Potr* 
presents a new versatile tool for fine-tuning gene expression in streptomycetes. 
Keywords 
Inducible expression system, streptomycetes, genetic parts, wide-range strength, 
biosynthetic gene cluster, natural product 
Introduction 
The Gram-positive streptomycetes are well-known producers of an immense diversity 
of biologically active compounds, which have been applied in human medicine, 
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animal health, and plant crop protection 
1
. In the past decades, a suite of genetic tools 
such as plasmids and constitutive promoters have been specifically developed for 
streptomycetes 
2-8
. These tools have greatly facilitated genetic manipulations of this 
genus. However, only a limited number of inducible expression systems are available 
for the precise control of gene expression in streptomycetes 
5
. 
Inducible expression systems are versatile genetic tools for controlling gene 
expression upon induction with chemical or physical inducers, and they are typically 
used for the functional characterization of genes and for the production of medically 
or industrially important proteins 
9, 10
. In many cases, inducible expression systems 
have also been employed to optimize the levels of pathway expression in order to 
achieve economically viable titers, yields and productivities of products of interest 
8, 11, 
12
. However, the existing inducible expression systems have their limitations and 
could not meet the need of synthetic biology to precise control gene expression in 
streptomycetes. The thiostrepton-inducible ptipA was the first inducible expression 
system developed from Streptomyces lividans 
13
. It depends on the presence of the 
activator TipAL but also relies on the resistance gene tsr, and it often show high level 
of leaky expression 
14, 15
. Other inducible expression systems developed for 
streptomycetes include the ε-caprolactam-inducible expression system based on the 
nitrilase promoter/operator PnitA/NitR from Rhodococcus rhodochrous 
16
, the 
synthetic tetracycline (Tc)-inducible expression system based on the repressor 
TetR/operator tetO from Escherichia coli 
17
 and the cumate-inducible system from 
Pseudomonas putida 
18
. While the PnitA/NitR inducible expression system is 
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excellent for protein overproduction from high copy number plasmids, it is unclear 
whether this system will also perform well to control expression in routine genetic 
analysis and metabolic pathway engineering 
17
. Importantly, the inducers 
ε-caprolactam and cumate are degradable in some Streptomyces species 
16, 19
, which 
will limit their applications. In addition, the above-mentioned genetic parts for 
inducible expression systems are not perfectly compatible in streptomycetes, which 
are characterized by large and high-GC content genomes and intricate regulatory 
networks 
20
. The regulatory networks of streptomycetes result in background noise 
when using these genetic parts 
17, 18
. For example, each streptomycetes genome 
contains over 100 TetR family regulators, and thus TetR homologs SCO0253 perturbs 
the work of the synthetic Tc-inducible expression system developed by TetR 
repressor and tetO operator in Streptomyces coelicolor 
17
. Therefore, although several 
inducible expression systems have been reported for streptomycetes 
15-18
, there is still 
a definitive lack of tightly inducible expression system suitable for elaborate studies 
in streptomycetes. 
Ideally, an inducible expression system should be completely turned off when 
repressed, and tunable to different strengths when induced. In addition, the inducer 
should be easily available and have little pleiotropic effects on growth 
9
. Streptomyces 
species exhibit marked regulatory capacity and flexibility 
20
. They typically have 
more than 8000 protein-coding genes, and >10% of the coding genes are predicted to 
be transcription factors 
20
. The native regulators and operators in the genomes of 
streptomycetes are therefore rich repositories of genetic parts that fulfill the 
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requirements for the development of inducible expression systems.  
In the present study, we aimed to find unique genetic parts that respond to small 
molecules in streptomycetes and to develop ideal inducible expression systems. 
Interestingly, regulatory genes situated in biosynthetic gene clusters (BGCs) that 
direct secondary metabolite biosynthesis do often interact with the products of that 
pathway and regulate the transcription of biosynthetic genes and/or resistance genes 
8,21
. For example, ActR 
22
, KijA8 
23
, LanK 
24
, SimR 
25
, and VarR 
26
 have all been 
reported to bind the end products or intermediates of the corresponding BGCs and 
induce the expression of divergently adjacent exporter genes. The regulatory 
mechanism is similar to the Tc-inducible repressor (TetR) and exporter (TetA) from 
the E. coli transposon Tn10 
23
. The well-characterized repressor TetR and operator 
tetO have been widely used as genetic parts to construct inducible expression systems 
in prokaryotes 
27
, mammalian cells 
28
 and other organisms (such as Drosophila 29). 
Here we therefore focused on the pairs of antibiotic exporter and regulatory genes 
from BGCs of streptomycetes to identify the candidate genetic parts. By combining 
the rareness of the regulators and the availability of the inducers, the oxytetracycline 
(OTC)-inducible regulator OtrR, operator otrO and promoter otrBp from 
Streptomyces rimosus were selected and characterized de novo. Using these 
well-characterized genetic parts, a synthetic and tightly controlled inducible 
expression system Potr* with wide-range OTC-inducible strength was developed. 
Potr* showed negligible leaky expression levels in the absence of the inducer OTC 
and high levels of induced expression in Streptomyces venezuelae, Streptomyces 
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coelicolor and Streptomyces albus. Furthermore, Potr* was used to activate the silent 
jadomycin BGC and to optimize the production of this antibiotic in S. venezuelae 
ISP5230, exemplifying the usefulness of this system in eliciting the production of 
silent and possibly cryptic antibiotic-like natural products in streptomycetes.  
Results and Discussion 
Search for parts in genomes of streptomycetes 
To develop a strict inducible expression system with minimum interference from 
endogenous regulators of streptomycetes, pairs of antibiotic exporter and regulator 
genes in the genomes of streptomycetes were selected to investigate candidate genetic 
parts. For ideal genetic parts, the inducers should be highly stable and easily available. 
Aromatic polyketides, synthesized by type II polyketide synthases in streptomycetes, 
are recalcitrant to be degraded in these producers 
30
. Therefore, we searched all type 
II polyketide BGCs with identified products from the genomes of streptomycetes, and 
extracted sequences of exporters as well as the divergently arranged putative 
regulators (Table 1). The regulators were identified as TetR, ArsR, MarR or DeoR 
family (Table 1). Previous studies have reported that intrinsic large numbers of TetR 
homologs may perturb the inducible expression system developed through other TetR 
family regulators 
17
, therefore this family regulators were excluded from this study. 
Considering the availability and cost of the inducers, we selected genetic parts from 
the commercialized type II polyketide BGCs. Only OTC and chlortetracycline (CTC) 
meet the criteria of being readily available as well as low cost. The putative regulators 
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of OTC and CTC exporters (OtrR and CtcS) belong to MarR family, which have 
many less members (approximate 20-30 members) compared with the TetR family in 
streptomycetes. To avoid the interference of native regulators in streptomycetes, the 
sequences of OtrR and CtcS were used as queries to conduct a BLASTp search 
against the local protein database containing the sequences of 569,791 proteins from 
streptomycetes deposited in UniProt. Highly homologous orthologs of OtrR and CtcS 
(> 30% identities) were not observed in most genomes of streptomycetes, except that 
of their native hosts, Streptomyces monomycini and Streptomyces griseoflavus. The 
results suggest that OtrR and CtcS are suitable candidates with minimum interference 
from other endogenous regulators in streptomycetes. Since OTC is known to be less 
toxic to microbial cells than CTC, we decided to investigate the regulatory 
mechanism of the OTC exporter to identify inducible genetic parts (Fig. 1). 
Characterization of the regulatory mechanism of OtrR 
The MarR family transcriptional regulators exist as dimers and bind palindromic 
sequences within target promoters, resulting in either transcriptional repression or 
activation 
31
. To confirm the regulatory role of OtrR on the putative target promoter 
otrBp, a Lux reporter system was constructed in heterologous host E. coli (Fig. 2a). 
The lux genes were directly controlled by otrBp, endowing the strains with the ability 
of bioluminescence (Fig. 2b). When an OtrR expression plasmid was transferred into 
E. coli harboring the lux reporter plasmid, the bioluminescence was severely 
repressed (Fig. 2b), indicating that OtrR could repress the expression of otrBp. 
Furthermore, when OTC was added, the bioluminescence was restored in a 
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dose-dependent manner (Fig. 2b). These results suggest that OtrR can sense and 
respond to OTC to de-repress the transcription of otrBp. More importantly, the 
concentration of OTC needed to completely unlock otrBp is approximately 2.5 µM, 
which is a concentration much lower than the minimal inhibitory concentration (MIC, 
approximate 10-30 µM). 
To further confirm the direct interaction of OtrR with otrBp, OtrR was expressed and 
purified from E. coli (Supplementary Fig. S1) and an electrophoretic mobility shift 
assay (EMSA) was performed with a probe of otrBp (P-otrB). As shown in Fig. 2c, 
OtrR could bind P-otrB in a concentration-dependent manner. The binding was shown 
to be specific, with no retardation was observed for the negative control probe of hrdB 
promoter (P-hrdB) (Supplementary Fig. S2). These results demonstrate that OtrR 
represses otrBp by direct interaction. The responses of OtrR/P-otrB complexes to 
OTC were also analyzed by EMSA in vitro. We observed that OtrR and P-otrB 
complexes would dissociate in the presence of OTC, and this dissociation effect also 
occurred in an OTC concentration-dependent manner (Fig. 2d). This data along with 
the results obtained from the in vivo Lux reporter system undoubtedly indicate that 
OtrR represses the transcription of otrBp by direct binding, and OTC releases this 
repression effect by attenuating the binding of OtrR, thus inducing the transcription of 
otrBp. 
Determination of OtrR operator otrO and the core promoter of otrBp  
To develop a new OTC-inducible expression system, it is necessary to identify the 
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operator of OtrR. DNase I footprinting was performed to locate the binding sites of 
OtrR in the otrBp region using a capillary sequencer. As shown in Fig. 3a, a fully 
protected region was observed in the presence of OtrR, and this region encompasses 
two 6-nt inverted repeats (GACAAG) with 2-bp spacing (Fig. 3b). To further confirm 
whether the identified region containing the palindromic sequence is the operator of 
OtrR (designated as otrO), we amplified the probes with (PR) or without (PL) the 
palindromic sequence (Supplementary Fig. S3a) and tested their binding with OtrR by 
EMSA. The results showed that the retardation was only observed with the PR probe 
(Supplementary Fig. S3b and c). Furthermore, the binding ability of the 20-bp probe 
(P20) containing the palindromic sequence with OtrR was examined using EMSA, 
and the retardation was readily detected (Supplementary Fig S3d). These results 
suggest that this palindromic sequence is the core region of otrO. To determine the 
equilibrium dissociation constant (KD) between the interaction of OtrR and otrO, 
surface plasmon resonance (SPR) was performed. The sequence containing otrO was 
labeled with biotin and immobilized onto a streptavidin sensor chip, and subsequently 
OtrR was injected. The sensorgrams showed increased binding with the increasing 
OtrR concentrations (Fig. 3c). The best fit for OtrR yielded KD value of 0.17 nM. The 
KD of interaction between OtrR and otrO is similar to that of the interaction between 
Tc-inducible repressor TetR and operator tetO, which have been successfully used as 
genetic parts for the development of inducible expression systems and the 
construction of genetic circuits in many organisms 
27-29
. Therefore, the new genetic 
parts OtrR and otrO show good potential for widespread application. Notably, OtrR, 
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containing only 165 amino acids, is smaller than TetR, which will enable a much 
easier and economical application in other organism. In addition, the operator of OtrR 
is very unique. A search using otrO sequence did not give closely matched sequences 
in the genomes of streptomycetes, suggesting that OtrR and otrO are ideal parts that 
do not interplay with host DNA or regulators in streptomycetes.  
To determine the loci of the otrO relative to the the transcriptional start site (TSS) of 
otrBp, rapid amplification of 5’-cDNA ends (5’-RACE) was performed (Fig. 3d). 
Then the putative -10 and -35 regions were identified based on the determined TSS 
(Fig. 3d), which shares high nucleotide sequence identity with the core promoter 
recognized by the essential sigma factor HrdB 
32
. After defining the core region of 
otrBp, otrO site was found to overlap with -35 region of otrBp (Fig. 3d).  
Development of the OTC-inducible expression system for streptomycetes 
OtrR and otrBp were identified from Streptomyces species, and thus the native 
otrR-otrBp inducible expression system (designated as Potr) should be compatible in 
streptomycetes. The performance of Potr was firstly evaluated in S. venezuelae, which 
grows in a diffuse and homogenous manner in a variety of liquid media 
33
. Such 
growth characteristics facilitate accurate data normalization. Strain S. venezuelae 
WVR2006::pIJ-Potr was incubated in MYM medium supplemented with OTC at 
concentrations ranging from 10 nM to 6 µM. We observed that GFP fluorescence 
increased with increasing concentrations of OTC and Potr was fully induced at 4 µM 
OTC (Fig. 4a). Surprisingly, the fully induced fluorescence was stronger than that 
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driven by the widely used constitutive promoters kasOp* 
2
 and ermEp* 
34
 (Fig. 4b), 
suggesting that the activity of otrBp was very strong. Recently, Bai et al. 
35
 has shown 
that kasOp* exhibited the strongest activity among all the tested constitutive 
promoters in streptomycetes using a flow cytometry-based quantitative method. At the 
fully induced state, we observed that the activity of native otrBp was stronger than 
that of kasOp* (Fig. 4b). Hence, the activity of otrBp does not require further 
optimization. However, we observed that the leaky expression without OTC induction 
was higher compared with the control (Fig. 4b). Thus, Potr should be engineered to 
reduce leaky expression. 
Zhang et al. 
36
 reported that the integration of the same operators at two locations, 
flanking the -35 and the -10 regions of the target promoter, can achieve tighter control 
of the promoter activity. To reduce the leaky expression of Potr, we engineered the 
inducible expression system (designated as Potr*) by inserting another operator 
downstream of the TSS of otrBp (Fig. 4c). After examining the GFP fluorescence of S. 
venezuelae WVR2006::pIJ-Potr* (map of pIJ-Potr*, see Supplementary Fig. S4), we 
observed that Potr* showed nearly the same GFP-response curve as Potr to OTC (Fig. 
4d), whereas the leaky expression was significantly reduced to a level similar to the 
control (Fig. 4e). 
To examine the activity of Potr* induced by different doses of OTC at the 
transcription level, real-time quantitative PCR (RT-qPCR) was performed to assess 
the transcript levels of the gfp gene in S. venezuelae WVR2006::pIJ-Potr*. The results 
showed that the transcript abundance of gfp increased in an OTC 
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concentration-dependent manner (Fig. 5a), suggesting that the inducible activity of 
Potr* was sensitively controlled at the transcriptional level in S. venezuelae.  
To evaluate the growth inhibitory effects by OTC, the growth of S. venezuelae was 
assayed in the presence OTC. The results indicate OTC does not have significant 
effects on growth at lower than 6 µM (Supplementary Fig. S5). As a concentration 
less than 4 µM OTC is sufficient to induce Potr or Potr* to a fully expressed level, the 
inducer can be used at a concentration where the growth is hardly affected. 
Evaluation of the performance of Potr* in different Streptomyces species 
To evaluate the inducible behavior of Potr* in other Streptomyces species, the 
production of GFP fluorescence under the control of Potr* was further evaluated in S. 
coelicolor M1146::pIJ-Potr* and S. albus J1074::pIJ-Potr*. It was shown that the 
expression of gfp was sensitively induced in a OTC concentration-dependent manner 
in the two hosts; the leaky expression of gfp was negligible without OTC and the fully 
induced output of gfp was much higher than that of the constitutive promoters kasOp* 
2
 and ermEp* 
34
 (Fig. 5b and c). When grown in liquid culture, S. coelicolor and S. 
albus form large pellets or clumps, meaning that the GFP fluorescence assay might 
have margins of error in the data normalization of these strains. Therefore, we further 
performed RT-qPCR to more accurately evaluate the transcription levels of gfp 
reporter gene in S. coelicolor M1146::pIJ-Potr* and S. albus J1074::pIJ-Potr* after 
induction using different OTC concentrations. The results showed that the transcript 
levels of the gfp gene also increased in an OTC concentration-dependent manner in 
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the two Streptomyces strains (Fig. 5d and e), consistent with the results obtained in S. 
venezuelae. The highly consistent results generated in different Streptomyces species 
indicate that Potr* is a tightly controlled inducible expression system with wide-range 
strength in streptomycetes. 
Application of Potr* in activation and optimization of the silent jadomycin BGC 
The potential for the production of high-value secondary metabolites is even larger 
than previously realized in streptomycetes 
21
. However, accessing this rich resource to 
identify new compounds through the activation of cryptic pathways is still a challenge. 
We hypothesized that a cryptic gene cluster under the control of an inducible 
expression system will facilitate the identification of corresponding product, as the 
production will increase with the inducer in a concentration-dependent manner. To 
demonstrate this application, we designed a plug-and-play plasmid pIW01 
(Supplementary Fig. S6) using the newly developed inducible expression system 
Potr*. This plasmid was integrated into the genome of S. venezuelae ISP5230 to drive 
the expression of silent jadomycin BGC 
37
 (Fig. 6a). As expected, jadomycin B 
production gradually increased with the OTC inducer (Fig. 6b), while the control 
without OTC induction showed almost no production, similar to the results of wild 
type S. venezuelae ISP5230. These results indicate that the inducible expression 
system can be applied in the activation and identification of silent and possibly cryptic 
natural products in streptomycetes.  
To improve the production of jadomycin, the expression levels of jadomycin BGC 
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were optimized by adding different doses of OTC at different growth time points. 
Accordingly, jadomycin B production under different induction conditions was 
examined. It was found that an induction dose of 0.75 µM OTC and time of 4 h was 
optimal (Fig. 6c). The use of an inducible expression system to optimize the 
production levels of secondary metabolites in streptomycetes is a promising approach 
for the improvement of antibiotics production. Previously, overexpression of BGCs or 
activators through constitutive strong promoters is a prefered approach 
38
. A potential 
disadvantage of these approaches is that the constitutive expression of BGCs leads to 
the synthesis of the products at early growth stage, which could reduce the growth of 
host cell and concomitantly decrease the overall production level 
39
. The strategy of 
fine-tuning the expression of BGCs could coordinate the biomass growth and desired 
product accumulation. Our results suggest that the inducible expression system Potr* 
can be applied as an optimizing tool in rational engineering.  
Overall, new genetic parts (repressor OtrR, operator otrO and promoter otrBp) were 
identified and characterized de novo. They have been shown to fulfill the 
requirements of inducible expression system. Then the synthetic inducible expression 
system Potr* was developed using these genetic parts, and it showed tightly tunable 
strength though the inducer OTC in streptomycetes. Potr* was also designed as a tool 
to activate silent gene clusters and to optimize the production of secondary 
metabolites. The present work suggests that the synthetic inducible expression system 
Potr* will play important roles on fine-tuning gene expression in streptomycetes and 
the newly characterized genetic parts will have potential to be used in the control of 
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gene expression and construction of genetic circuits in synthetic biology. 
Methods 
Bacterial strains and culture conditions 
The strains and plasmids used in the present study are listed in Supplementary Table 
S1. E. coli JM109 and DH5α were used for cloning and bioluminescence assays, 
respectively; BL21(DE3) was used for the recombinant expression of OtrR protein. E. 
coli strains were grown in Luria-Bertani (LB) medium containing ampicillin (100 
µg/ml), hygromycin (50 µg/ml), kanamycin (25 µg/ml) or chloramphenicol (25 µg/ml) 
when necessary. For spore preparations, Streptomyces coelicolor M1146 
40
, 
Streptomyces albus J1074 
41
, Streptomyces rimosus M4018 
39
 and their derivatives 
were maintained on mannitol-soya flour (MS) agar plates 
7
, while Streptomyces 
venezuelae ISP5230, S. venezuelae WVR2006 
42
 and its derivatives were grown on 
maltose-yeast extract-malt extract (MYM) agar plates 
7
. For DNA and total RNA 
preparation, S. rimosus M4018 was grown in TSB medium 
39
. For GFP reporter 
assays, the derivatives of S. coelicolor M1146 and S. albus J1074 were grown in 
supplemented minimum medium (SMM) 
7
, while the derivatives of S. venezuelae 
WVR2006 were grown in MYM liquid medium.  
Construction of plasmids 
All primers used in the present study are listed in Supplementary Table S2. For the 
construction of pET-OtrR, otrR was amplified from the genomic DNA of S. rimosus 
4018 with primer pair OtrRF1/OtrRR1. The product was digested with NdeI/XhoI and 
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inserted into the corresponding sites of pET-23b. For the construction of pLux-otrBp, 
otrBp was amplified from genomic DNA of S. rimosus 4018 with primer pair 
PBF1/PBR1. The product was digested with BamHI/XhoI and inserted into the 
corresponding sites of pCS26-Pac 
43
. For the construction of pOtrR, otrR was 
amplified using the primer pair OtrRF2/OtrRR2, and a fragment of plasmid backbone 
was amplified from pACYC184 using the primer pair 184F/184R. The two fragments 
were assembled using the In-Fusion cloning kit (Clontech) to generate pOtrR. For the 
construction of pIJ-Potr, a 637-bp fragment containing otrR and otrBp was amplified 
from S. rimosus 4018 genomic DNA using the primer pair PBF2/PBR2, and 
enzymatically assembled with pIJ8660::BsaI-sfgfp 
35
 digested by BsaI to generate 
pIJ-Potr 
44
. To construct pIJ-Potr*, a fragment of plasmid backbone was amplified 
from pIJ-Potr using the primer pair IJF2/IJR2 and subsequently self-ligated through 
enzymatic assembly to generate pIJ-Potr*. For the construction of plug-and-play 
plasmids, a fragment of the plasmid backbone was amplified from pIJ-Potr* using the 
primer pair IJF3/IJR3 and subsequently self-ligated to remove the sequences of attP 
and integrase gene to generate pIW. A fragment of plasmid backbone was amplified 
from pIW using the primer pair IWF1/IWR1 to remove the gfp gene, followed by 
self-ligation through enzymatic assembly to generate pIW01. For the construction of 
pIW01-jad, 5’-partial jadJ was amplified from S. venezuelae ISP5230 genomic DNA 
using the primer pair JF/JR, and a fragment of plasmid backbone was amplified from 
pIW01 using the primer pair IWF/IWR. Subsequently, the two fragments were 
enzymatically assembled to generate pIW01-jad. 
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Expression and purification of OtrR 
The plasmid pET-OtrR was introduced into E. coli BL21 (DE3) for recombinant 
expression of OtrR. These proteins were purified as previously described 
45
. 
EMSA 
A probe for otrBp was amplified using the primers PBF4/PBR4 (Table S2). The probe 
was incubated with varying concentrations of puriﬁed OtrR at 25°C for 30 min in 20 
µl of buffer containing 20 mM Tris-base (pH 7.5), 2 mM dithiothreitol, 5 mM MgCl2, 
0.5 mg/ml calf BSA and 5% glycerol. After incubation and electrophoresis, the 
non-denaturing 4% polyacrylamide gels were stained with SYBR Gold Nucleic Acid 
Gel Stain (Invitrogen) for 30 min in TBE (89 mM Tris-base, 89 mM boric acid, and 1 
mM EDTA, pH 8.0), and photographed under an ultraviolet trans-illuminator using 
Bio-Rad GelDoc XR. 
Luciferase assays in vivo using Lux reporter systems 
The plasmid pLux-otrBp and control pCS26-Pac 
43
 were introduced into E. coli DH5α. 
Subsequently, pOtrR was introduced into DH5α harboring pLux-otrBp to examine the 
effects of OtrR on otrBp. For luciferase assays, approximately 10
6
 cells were 
inoculated into 5 ml of LB for 12 h. Then the bioluminescence of E. coli cultures was 
measured using an EnSpire Multimode Reader (PerkinElmer).  
DNase I footprinting assay 
DNase I footprinting assays were performed through fluorescent labeling and 
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capillary analyses 
46
. Briefly, DNA fragments were prepared through PCR using 
fluorescence-labeled primers PBF5/PBR4. After purification from agarose gel, the 
labeled DNA fragments (120 ng) and respective concentrations of proteins were 
added to a final reaction volume of 50 µl, and incubated at 25°C for 20 min. Then the 
fragments were digested with DNase I (Promega) for 1 min at 25°C and terminated 
using stop buffer (Promega). After phenol-chloroform extraction and ethanol 
precipitation, the samples were loaded onto an Applied Biosystems 3730 DNA 
genetic analyzer (Applied Biosystems) together with the internal-lane size standard 
ROX-500 (Applied Biosystems). A dye primer-based sequencing kit (Thermo) was 
used to precisely determine the sequences after aligning the results of the capillary 
electrophoresis reactions. The electrophoregrams were subsequently analyzed with 
the GeneMarker v1.8 software.  
Determination of TSS 
5’-RACE experiments were conducted to map the transcriptional start points of otrBp 
according to the manufacturer's instructions (RLM-RACE kit, Ambion). The total 
RNA was extracted from S. rimosus M4018. GSPB1 was used as special outer otrB 
primer, and GSPB2 was used as special inner otrB primer, respectively.  
SPR assays 
The SPR assays were conducted using a Biacore 3000 System (GE Healthcare). The 
experiments were performed in PBS buffer (9 mM PBS, pH 7.4, 1% DMSO and 0.05% 
Tween 20) with a flow rate of 30 µl/min at 25°C. The probe was obtained after 
Page 18 of 39
ACS Paragon Plus Environment
ACS Synthetic Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
19 
 
annealing the biotin-labeled forward primer SPRF and the unlabeled reverse primer 
SPRR, and then immobilized on a streptavidin sensor chip. OtrR was diluted to 
different concentrations in PBS buffer and subsequently injected. At the end of each 
cycle, 0.4% SDS was used to regenerate the surface. The data fitting for the binding 
model was conducted using BIA evaluation 4.1 software (GE Healthcare).  
Quantitative measurement of GFP fluorescence 
For S. venezuelae, 1 ml of the 24-h seed cultures of the recombinant strains was 
inoculated into 50 ml of MYM medium for 6 h, then induced by different doses of 
OTC for 18 h. 200-µl aliquots of the cultures were washed twice with PBS (pH 7.2) 
and re-suspended with 1ml PBS, then GFP fluorescence was detected (excitation at 
485 nm; emission at 512 nm, Synergy H4 Multi-Mode Reader). All fluorescence 
values were normalized to cell growth (OD600). For S. coelicolor and S. albus, 
approximately 2×10
8
 spores were inoculated into 50 ml of SMM medium for 48 and 
42 h, respectively. Subsequently, the cells were washed twice with PBS (pH 7.2). The 
pellets were re-suspended in 1 ml R buffer (20 mM Tris-HCl, 0.5 M NaCl, and 10% 
(v/v) glycerol, pH 7.4) and subjected to ultra-sonication to generate a cell extract 
3
. 
The fluorescence intensity was quantified after normalizing the fluorescence intensity 
to the protein concentration in the 200-µl sample 
3
. Each value and error bar 
represents the average and standard deviation of three experimental replicates, 
respectively. 
Transcriptional analysis using RT-qPCR 
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Total RNA was isolated from Streptomyces samples using a standard procedure 
7
 at 
the same time as GFP fluorescence assay. The RNA samples were then treated with 
RNase-free DNase (Progema) and checked by PCR to eliminate the possibility of 
chromosomal DNA contamination. First-strand cDNA of gfp gene was performed 
using a Superscript III first-strand Synthesis System (Invitrogen) with 500 ng of total 
RNA according to the manufacturer’s instructions. All cDNA synthesis reactions 
included a replicate reaction without reverse transcriptase to ensure the complete 
removal of contaminating DNA from the RNA samples. The primers of gfp and hrdB 
are listed in Supplementary Table S2. RT-qPCR was performed using the ABI 7500 
Detection System and SYBR Green PCR Master Mix (Applied Biosystems). The 
results were analyzed using ABI 7500 software v2.0.1 and the relative expression 
levels of the target genes were normalized to endogenous hrdB levels. All samples 
were analyzed in triplicate. 
Activation of jadomycin BGC and optimization of jadomycin production 
The plasmid pIW01-jad was introduced into E. coli ET12567 (pUZ8002) and 
conjugated into S. venezuelae ISP5230. Recombinant strains were incubated in 96 
deep-well plates after the introduction of OTC at different time points and dose at 
30
o
C with shaking (900 rpm), then the production of jadomycin B was examined. The 
HPLC condition for the detection of jadomycin B was the same as previously 
described 
42
.  
Supporting Information Available 
Supplementary Figures, Tables and Sequences. This material is available free of 
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Figure legends and tables 
Figure 1 Position and arrangement of otrR and otrB genes in the OTC BGC. 
Figure 2 Identification of the repression effect of OtrR and the de-repression effect of 
OTC. (a) Schematic representation of the Lux reporter system. (b) OtrR represses the 
bioluminescence controlled by otrBp and OTC induces the bioluminescence in vivo. 
All values are presented in relative light units (RLU) and represented as the means ± 
SD from at least three independent experiments. (c) EMSA of the interaction between 
the P-otrB and OtrR. Each lane contains 6 ng of P-otrB and different amounts of OtrR. 
(d) Dissociation effect of the DNA-binding activity of OtrR in the presence of OTC. 
Each lane contains 6 ng of P-otrB, 0.15 µM OtrR and different amounts of OTC.  
Figure 3 Characterization of the interaction between the operator otrO and OtrR. (a) 
Capillary electrophoregram of the DNase I digestion reaction of otrBp protected by 
0.15 µM OtrR. (b) Capillary electrophoregram of sequencing reactions of otrBp 
aligned by GeneMarker v1.8 software. The sequence around the protected region is 
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indicated below the electrophoregrams, and the palindromic sequence of the protected 
region is indicated with arrows. (c) SPR analysis of the equilibrium dissociation 
constant (KD) of the interaction between OtrR and otrO. (d) Nucleotide sequences of 
the core region of otrBp. The transcriptional start site (TSS) is indicated with an 
asterisk. The operator otrO characterized with inverted repeat sequences is indicated 
with arrows. The presumptive -10 and -35 regions of otrBp are indicated with boxes. 
Figure 4 Development of the inducible expression system Potr*. (a) Expression 
levels of Potr in response to different doses of OTC measured by GFP fluorescence. 
The inducer concentrations were 0, 0.01, 0.02, 0.04, 0.08, 0.2, 0.4, 0.8, 1.6, 2, 3, 4, 5, 
and 6 µM OTC. The values are presented as the means ± SD of three independent 
experiments. (b) Activity of the on and off state of Potr. 4 µM OTC was used to fully 
induce the activity of Potr. (c) Core promoter sequences of the native Potr and the 
developed Potr*. The TSS is indicated with an asterisk. The presumptive -10 and -35 
regions are indicated with boxes, and the operator otrO is underlined. (d) Expression 
levels of Potr* in response to different doses of OTC measured by GFP reporter. The 
same OTC concentrations as in A were used. (e) Activity of the on and off state of 
Potr*. 4 µM OTC was used to fully induce the activity. 
Figure 5 Evaluation of the performance of Potr* in different Streptomyces species. (a) 
Quantitative analyses of the transcript levels of gfp controlled by Potr* in response to 
OTC in S. venezuelae. The relative value of gfp transcript controlled by the 
constitutive promoter ermE* was arbitrarily assigned as one. (b) GFP fluorescence in 
response to different doses of OTC in S. coelicolor M1146. (c) GFP fluorescence in 
Page 29 of 39
ACS Paragon Plus Environment
ACS Synthetic Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
30 
 
response to different doses of OTC in S. albus J1074. (d) Quantitative analyses of the 
transcript level of gfp controlled by Potr* in response to OTC in S. coelicolor M1146. 
The relative value of gfp transcript controlled by ermE* was arbitrarily assigned as 
one. (e) Quantitative analyses of the transcript level of gfp in response to OTC in S. 
albus J1074. The relative value of gfp transcript controlled by ermE* was arbitrarily 
assigned as one. For a, b, c, d and e, the values are presented as the means ± SD of 
three independent experiments and the control is a strain containing a plasmid 
(pIJ8660::BsaI-sfgfp) with promoterless gfp. 
Figure 6 Application of Potr* for the activation of the silent jadomycin BGC and the 
optimization of jadomycin production. (a) Schematic representation of the strategy to 
activate or optimize the expression of the jadomycin BGC. pIW01 is the plasmid 
containing the inducible expression system Potr* and the multiple cloning site (MCS) 
for inserting the target fragment. (b) The activation and identification of the product 
of silent jadomycin BGC through induction using gradient doses of OTC. (c) Heat 
map showing the production of jadomycin B for all combinations of different OTC 
doses and induction time points. 
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Table 1 Pairs of antibiotic exporter and regulatory genes of in type II polyketide synthesis clusters. 
Streptomyces 
species 
Type II polyketide Transporter  Regulator/family Effector
a
 GenBank accession 
number 
S. coelicolor Actinorhodin ActII-ORF2 ActII-ORF1/TetR family (S)-DNPA; kalafungin M64683  
S. sp. CM020 Alnumycin AlnT1 AlnR8/MarR family NA EU852062 
S. maritimus Enterocin EncT EncS/TetR family NA AF254925 
S. griseoflavus Gilvocarcin GilJ GilI/DeoR family NA AY233211 
S. cyanogenus Landomycin LanJ LanK/TetR family landomycin A and B AF080235 
S. glaucescens  Tetracenomycin TcmA TcmR/TetR family  Tetracenomycin M80674 
S. antibioticus Oviedomycin OvmE Orf3/ArsR family NA AJ632203 
S. rimosus Oxytetracycline OtrB OtrR/MarR family NA DQ143963 
S. aureofaciens Chlortetracycline CtcR CtcS/MarR family NA HM627755 
S. steffisburgensis Steffimycin SfrB StfRIII/MarR family NA AM156932 
S. fradiae Tü2717 Urdamycin UrdJ UrdK/TetR family NA AF164961 
S. antibioticus Simocyclinone SimX SimR/TetR family Simocyclinone D8 and C4 AF324838 
a 
NA indicate the unknown effector.
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Figure 1 Position and arrangement of otrR and otrB genes in the OTC BGC.  
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Figure 2 Identification of the repression effect of OtrR and the de-repression effect of OTC. (a) Schematic 
representation of the Lux reporter system. (b) OtrR represses the bioluminescence controlled by otrBp and 
OTC induces the bioluminescence in vivo. All values are presented in relative light units (RLU) and 
represented as the means ± SD from at least three independent experiments. (c) EMSA of the interaction 
between the P-otrB and OtrR. Each lane contains 6 ng of P-otrB and different amounts of OtrR. (d) 
Dissociation effect of the DNA-binding activity of OtrR in the presence of OTC. Each lane contains 6 ng of P-
otrB, 0.15 µM OtrR and different amounts of OTC.  
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Figure 3 Characterization of the interaction between the operator otrO and OtrR. (a) Capillary 
electrophoregram of the DNase I digestion reaction of otrBp protected by 0.15 µM OtrR. (b) Capillary 
electrophoregram of sequencing reactions of otrBp aligned by GeneMarker v1.8 software. The sequence 
around the protected region is indicated below the electrophoregrams, and the palindromic sequence of the 
protected region is indicated with arrows. (c) SPR analysis of the equilibrium dissociation constant (KD) of 
the interaction between OtrR and otrO. (d) Nucleotide sequences of the core region of otrBp. The 
transcriptional start site (TSS) is indicated with an asterisk. The operator otrO characterized with inverted 
repeat sequences is indicated with arrows. The presumptive -10 and -35 regions of otrBp are indicated with 
boxes.  
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Figure 4 Development of the inducible expression system Potr*. (a) Expression levels of Potr in response to 
different doses of OTC measured by GFP fluorescence. The inducer concentrations were 0, 0.01, 0.02, 0.04, 
0.08, 0.2, 0.4, 0.8, 1.6, 2, 3, 4, 5, and 6 µM OTC. The values are presented as the means ± SD of three 
independent experiments. (b) Activity of the on and off state of Potr. 4 µM OTC was used to fully induce the 
activity of Potr. (c) Core promoter sequences of the native Potr and the developed Potr*. The TSS is 
indicated with an asterisk. The presumptive -10 and -35 regions are indicated with boxes, and the operator 
otrO is underlined. (d) Expression levels of Potr* in response to different doses of OTC measured by GFP 
reporter. The same OTC concentrations as in a were used. (e) Activity of the on and off state of Potr*. 4 µM 
OTC was used to fully induce the activity of Potr*.  
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Figure 5 Evaluation of the performance of Potr* in different Streptomyces species. (a) Quantitative analyses 
of the transcript levels of gfp controlled by Potr* in response to OTC in S. venezuelae. The relative value of 
gfp transcript controlled by the constitutive promoter ermE* was arbitrarily assigned as one. (b) GFP 
fluorescence in response to different doses of OTC in S. coelicolor M1146. (c) GFP fluorescence in response 
to different doses of OTC in S. albus J1074. (d) Quantitative analyses of the transcript level of gfp controlled 
by Potr* in response to OTC in S. coelicolor M1146. The relative value of gfp transcript controlled by ermE* 
was arbitrarily assigned as one. (e) Quantitative analyses of the transcript level of gfp in response to OTC in 
S. albus J1074. The relative value of gfp transcript controlled by ermE* was arbitrarily assigned as one. For 
a, b, c, d and e, the values are presented as the means ± SD of three independent experiments and the 
control is a strain containing a plasmid (pIJ8660::BsaI-sfgfp) with promoterless gfp.  
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Figure 6 Application of Potr* for the activation of the silent jadomycin BGC and the optimization of 
jadomycin production. (a) Schematic representation of the strategy to activate or optimize the expression of 
the jadomycin BGC. pIW01 is the plasmid containing the inducible expression system Potr* and the multiple 
cloning site (MCS) for inserting the target fragment. (b) The activation and identification of the product of 
silent jadomycin BGC through induction using gradient doses of OTC. (c) Heat map showing the production 
of jadomycin B for all combinations of different OTC doses and induction time points.  
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